bispectral index during general anesthesia induction
Conditions
Interventions
R Group:remazolam 0.3mg/kg iv.
P Group:Propofol 2mg/kg iv.
RS Group:remazolam 0.3mg/kg combine with sufentanil 0.3ug/kg iv.
RC Group:remazolam 0.3mg/kg iv.
Sponsors
The Second People's Hospital Of Foshan
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: ASA grade I-II patients scheduled for elective endotracheal intubation under general anesthesia, aged 18-65 years, of both sexes, with a body mass index of 18-28, who volunteered to participate in this study and signed informed consent.
Exclusion criteria
Exclusion criteria: Allergic to remazolam and its adjuvant; People who are dependent on opioids or have used opioids, sedatives or psychotropic drugs in the past week; Severe heart, brain, liver and kidney diseases; Difficult airway; The patient declined to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| bispect ral index;bispect ral index; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood Pressure;Heart rate;MOAA/S;Blood oxygen saturation; | — |
Countries
China
Contacts
Public ContactXianjie Wen
The Second People's Hospital Of Foshan
Outcome results
None listed